NRXP NRx Pharmaceuticals | $2.35
+13.5% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $19.00 -> $19.00 | High | View details for HC Wainwright rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/14/2025 |
CADL Candel Therapeutics | $8.75
+10.2% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $19.00 -> $19.00 | High | View details for HC Wainwright rating of Candel Therapeutics (NASDAQ:CADL) on 3/14/2025 |
AKBA Akebia Therapeutics | $2.26
+33.7% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $7.50 -> $7.50 | High | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 3/14/2025 |
INAB IN8bio | $0.23
-0.4% | 3/14/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $8.00 -> $6.00 | Medium | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 3/14/2025 |
RNAC Cartesian Therapeutics | $15.80
-4.9% | 3/14/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $45.00 -> $40.00 | High | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 3/14/2025 |
PRQR ProQR Therapeutics | $1.69
-2.9% | 3/14/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $10.00 -> $12.00 | High | View details for HC Wainwright rating of ProQR Therapeutics (NASDAQ:PRQR) on 3/14/2025 |
ACIU AC Immune | $2.29
-0.4% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 3/14/2025 |
KALV KalVista Pharmaceuticals | $12.60
+2.9% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 3/14/2025 |
VIGL Vigil Neuroscience | $2.02
-4.3% | 3/14/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $17.00 -> $14.00 | High | View details for HC Wainwright rating of Vigil Neuroscience (NASDAQ:VIGL) on 3/14/2025 |
EMX EMX Royalty | $1.85
| 3/14/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $7.00 -> $5.00 | N/A | View details for HC Wainwright rating of EMX Royalty (NYSEAMERICAN:EMX) on 3/14/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
AMTX Aemetis | $1.68
+5.7% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $28.00 -> $28.00 | High | View details for HC Wainwright rating of Aemetis (NASDAQ:AMTX) on 3/14/2025 |
SOL Emeren Group | $1.19
-19.4% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Emeren Group (NYSE:SOL) on 3/14/2025 |
BLNK Blink Charging | $0.95
+6.0% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Sameer Joshi | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of Blink Charging (NASDAQ:BLNK) on 3/14/2025 |
PHAR Pharming Group | $8.77
+0.3% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $37.00 -> $37.00 | Medium | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 3/14/2025 |
ATYR Atyr PHARMA | $3.97
-0.5% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $35.00 -> $35.00 | Medium | View details for HC Wainwright rating of Atyr PHARMA (NASDAQ:ATYR) on 3/14/2025 |
TRML Tourmaline Bio | $18.80
+10.3% | 3/14/2025 | Target Raised by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $49.00 -> $50.00 | High | View details for HC Wainwright rating of Tourmaline Bio (NASDAQ:TRML) on 3/14/2025 |
LYRA Lyra Therapeutics | $0.17
-1.7% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Neutral -> Neutral | $2.00 -> $2.00 | High | View details for HC Wainwright rating of Lyra Therapeutics (NASDAQ:LYRA) on 3/14/2025 |
RGLS Regulus Therapeutics | $1.48
+7.2% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for HC Wainwright rating of Regulus Therapeutics (NASDAQ:RGLS) on 3/14/2025 |
IPA ImmunoPrecise Antibodies | $0.38
-5.0% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of ImmunoPrecise Antibodies (NASDAQ:IPA) on 3/14/2025 |
PDSB PDS Biotechnology | $1.23
-2.4% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $21.00 -> $21.00 | Low | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 3/13/2025 |
IBRX ImmunityBio | $2.87
-1.0% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 3/13/2025 |
FEMY Femasys | $1.57
+12.1% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 3/13/2025 |
NKTR Nektar Therapeutics | $0.90
+10.0% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Buy | $6.50 -> $6.50 | High | View details for HC Wainwright rating of Nektar Therapeutics (NASDAQ:NKTR) on 3/13/2025 |
UEC Uranium Energy | $5.08
-2.1% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $12.25 -> $12.25 | N/A | View details for HC Wainwright rating of Uranium Energy (NYSEAMERICAN:UEC) on 3/13/2025 |
VYGR Voyager Therapeutics | $3.90
-4.2% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 3/13/2025 |
AEYE AudioEye | $11.34
+3.4% | 3/13/2025 | Target Lowered by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $37.00 -> $22.00 | High | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 3/13/2025 |
VANI Vivani Medical | $1.09
+2.8% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Vivani Medical (NASDAQ:VANI) on 3/13/2025 |
OCS Oculis | $18.77
+0.4% | 3/13/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $30.00 -> $29.00 | Low | View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 3/13/2025 |
ZVRA Zevra Therapeutics | $8.31
+4.7% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 3/13/2025 |
LYEL Lyell Immunopharma | $0.59
-3.4% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Neutral | $1.00 -> $1.00 | High | View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 3/13/2025 |
EDSA Edesa Biotech | $2.39
+0.4% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $21.00 -> $21.00 | Medium | View details for HC Wainwright rating of Edesa Biotech (NASDAQ:EDSA) on 3/13/2025 |
ECOR electroCore | $8.56
-10.4% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of electroCore (NASDAQ:ECOR) on 3/13/2025 |
CATX Perspective Therapeutics | $2.59
-1.1% | 3/13/2025 | Initiated by | HC Wainwright | Analyst Robert Burns | Buy | $10.00 | High | View details for HC Wainwright rating of Perspective Therapeutics (NYSE:CATX) on 3/13/2025 |
ASM Avino Silver & Gold Mines | $1.75
-1.1% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.90 -> $2.20 | High | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 3/12/2025 |
ASM Avino Silver & Gold Mines | $1.76
+42.7% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.90 -> $2.20 | High | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 3/12/2025 |
OPK OPKO Health | $1.74
+1.2% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $3.00 -> $3.00 | Low | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 3/12/2025 |
CLNN Clene | $4.43
+1.4% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 3/12/2025 |
LEGN Legend Biotech | $37.20
-2.2% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $73.00 -> $75.00 | Medium | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 3/12/2025 |
HUMA Humacyte | $3.04
+9.7% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $15.00 -> $15.00 | Low | View details for HC Wainwright rating of Humacyte (NASDAQ:HUMA) on 3/12/2025 |
EVEX EVE | $3.19
-2.9% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of EVE (NYSE:EVEX) on 3/12/2025 |
A brutally honest economic warning for 2025 (see proof) (Ad) New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says.... Full details here. |
RDW Redwire | $10.61
+13.1% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $26.00 -> $26.00 | High | View details for HC Wainwright rating of Redwire (NYSE:RDW) on 3/12/2025 |
EXK Endeavour Silver | $4.72
+0.3% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $7.00 -> $7.25 | High | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 3/12/2025 |
DNTH Dianthus Therapeutics | $21.33
+0.2% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Dianthus Therapeutics (NASDAQ:DNTH) on 3/12/2025 |
MYO Myomo | $5.19
+2.4% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $7.50 -> $9.50 | N/A | View details for HC Wainwright rating of Myomo (NYSEAMERICAN:MYO) on 3/12/2025 |
IMCR Immunocore | $28.80
+1.9% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $100.00 -> $100.00 | Low | View details for HC Wainwright rating of Immunocore (NASDAQ:IMCR) on 3/12/2025 |
GERN Geron | $1.64
-1.8% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | | High | View details for HC Wainwright rating of Geron (NASDAQ:GERN) on 3/12/2025 |
AGEN Agenus | $1.86
+11.0% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Neutral -> Neutral | | High | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 3/12/2025 |
ATOS Atossa Therapeutics | $0.72
+5.0% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 3/12/2025 |
MURA Mural Oncology | $3.90
+6.6% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for HC Wainwright rating of Mural Oncology (NASDAQ:MURA) on 3/12/2025 |
HOWL Werewolf Therapeutics | $1.20
-0.8% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for HC Wainwright rating of Werewolf Therapeutics (NASDAQ:HOWL) on 3/12/2025 |
CRBP Corbus Pharmaceuticals | $6.79
+5.8% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $75.00 -> $50.00 | Low | View details for HC Wainwright rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 3/12/2025 |
BWAY BrainsWay | $10.21
| 3/12/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of BrainsWay (NASDAQ:BWAY) on 3/12/2025 |
ZYXI Zynex | $2.97
+2.4% | 3/12/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $17.00 -> $15.00 | High | View details for HC Wainwright rating of Zynex (NASDAQ:ZYXI) on 3/12/2025 |
LFMD LifeMD | $5.94
+4.9% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $12.00 -> $14.00 | Medium | View details for HC Wainwright rating of LifeMD (NASDAQ:LFMD) on 3/12/2025 |
SGMT Sagimet Biosciences | $3.74
+6.6% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $32.00 -> $32.00 | Low | View details for HC Wainwright rating of Sagimet Biosciences (NASDAQ:SGMT) on 3/11/2025 |
JSPR Jasper Therapeutics | $5.49
+2.0% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $40.00 -> $40.00 | Medium | View details for HC Wainwright rating of Jasper Therapeutics (NASDAQ:JSPR) on 3/11/2025 |
ATXS Astria Therapeutics | $6.45
-2.9% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 3/11/2025 |
CORZ Core Scientific | $8.81
+1.7% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for HC Wainwright rating of Core Scientific (NASDAQ:CORZ) on 3/11/2025 |
OLMA Olema Pharmaceuticals | $4.41
+0.9% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 3/11/2025 |
AA Alcoa | $33.56
+3.9% | 3/11/2025 | Target Raised by | HC Wainwright | - | Buy | $90.00 | Low | View details for HC Wainwright rating of Alcoa (NYSE:AA) on 3/11/2025 |
ARVN Arvinas | $8.43
-1.4% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $81.00 -> $81.00 | High | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 3/11/2025 |
VKTX Viking Therapeutics | $30.89
+3.9% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $102.00 -> $102.00 | High | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 3/11/2025 |
ATNM Actinium Pharmaceuticals | $1.23
+2.5% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSE:ATNM) on 3/11/2025 |
ALGS Aligos Therapeutics | $11.44
+11.3% | 3/11/2025 | Target Lowered by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $75.00 -> $70.00 | Low | View details for HC Wainwright rating of Aligos Therapeutics (NASDAQ:ALGS) on 3/11/2025 |
FNV Franco-Nevada | $153.45
+2.2% | 3/11/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $155.00 -> $165.00 | Low | View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 3/11/2025 |
WWR Westwater Resources | $0.63
+5.4% | 3/11/2025 | Initiated by | HC Wainwright | Analyst Heiko Ihle | Buy | $2.50 | High | View details for HC Wainwright rating of Westwater Resources (NASDAQ:WWR) on 3/11/2025 |
INUV Inuvo | $0.38
+3.6% | 3/11/2025 | Initiated by | HC Wainwright | Analyst Scott Buck | Buy | $2.00 | Low | View details for HC Wainwright rating of Inuvo (NYSE:INUV) on 3/11/2025 |
CHRS Coherus BioSciences | $0.92
+3.3% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $7.00 -> $7.00 | Medium | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 3/11/2025 |
TNYA Tenaya Therapeutics | $0.70
+4.3% | 3/11/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $18.00 -> $5.00 | High | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/11/2025 |
LCTX Lineage Cell Therapeutics | $0.52
| 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 3/11/2025 |
CKPT Checkpoint Therapeutics | $3.97
-0.5% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Neutral | $4.10 | Low | View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 3/11/2025 |
INZY Inozyme Pharma | $1.00
+0.0% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Inozyme Pharma (NASDAQ:INZY) on 3/11/2025 |
LFWD ReWalk Robotics | $1.51
-5.6% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of ReWalk Robotics (NASDAQ:LFWD) on 3/11/2025 |
ENGN enGene | $5.40
+0.9% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of enGene (NASDAQ:ENGN) on 3/11/2025 |
URGN UroGen Pharma | $11.07
+1.6% | 3/11/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $64.00 -> $55.00 | High | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 3/11/2025 |
FENC Fennec Pharmaceuticals | $6.51
+6.2% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 3/11/2025 |
TRVI Trevi Therapeutics | $6.75
+7.3% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $7.50 -> $12.50 | High | View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/10/2025 |
ONCY Oncolytics Biotech | $0.63
+0.3% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 3/10/2025 |
ZYME Zymeworks | $12.25
-2.4% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Neutral -> Neutral | $12.00 -> $13.00 | Low | View details for HC Wainwright rating of Zymeworks (NYSE:ZYME) on 3/10/2025 |
MLYS Mineralys Therapeutics | $14.25
+5.6% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Mineralys Therapeutics (NASDAQ:MLYS) on 3/10/2025 |
BEAM Beam Therapeutics | $24.23
-3.3% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 3/10/2025 |
JAZZ Jazz Pharmaceuticals | $137.96
+1.4% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $200.00 -> $217.00 | Low | View details for HC Wainwright rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 3/10/2025 |
CDTX Cidara Therapeutics | $22.05
-1.4% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $24.00 -> $35.00 | High | View details for HC Wainwright rating of Cidara Therapeutics (NASDAQ:CDTX) on 3/10/2025 |
GEVO Gevo | $1.24
+4.2% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 3/10/2025 |
PTGX Protagonist Therapeutics | $54.78
-0.2% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $54.00 -> $54.00 | High | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 3/10/2025 |
ELEV Elevation Oncology | $0.53
+6.9% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 3/10/2025 |
SLDB Solid Biosciences | $5.09
-1.0% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Arthur He | Buy -> Buy | $16.00 -> $20.00 | High | View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 3/10/2025 |
UBX Unity Biotechnology | $1.77
-1.1% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $8.00 -> $8.00 | High | View details for HC Wainwright rating of Unity Biotechnology (NASDAQ:UBX) on 3/10/2025 |
ALMS Alumis | $4.57
-0.4% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $19.00 -> $19.00 | Low | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 3/10/2025 |
CDXC ChromaDex | $7.84
+1.6% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $8.00 -> $11.00 | Low | View details for HC Wainwright rating of ChromaDex (NASDAQ:CDXC) on 3/10/2025 |
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia…
Listen up, because according to Nvidia's own CEO…
Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th. |
AQST Aquestive Therapeutics | $2.84
+4.4% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 3/10/2025 |
RAPT RAPT Therapeutics | $1.14
-2.6% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 3/10/2025 |
NUVB Nuvation Bio | $2.14
-3.4% | 3/10/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $11.00 -> $10.00 | High | View details for HC Wainwright rating of Nuvation Bio (NYSE:NUVB) on 3/10/2025 |
OBIO Orchestra BioMed | $4.08
+6.3% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of Orchestra BioMed (NASDAQ:OBIO) on 3/10/2025 |
IFRX InflaRx | $1.19
+3.5% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 3/7/2025 |
ARCT Arcturus Therapeutics | $14.08
+1.3% | 3/7/2025 | Target Lowered by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $63.00 -> $60.00 | High | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 3/7/2025 |
PDSB PDS Biotechnology | $1.23
-2.4% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $21.00 -> $21.00 | High | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 3/7/2025 |
BKSY BlackSky Technology | $9.08
+3.2% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of BlackSky Technology (NYSE:BKSY) on 3/7/2025 |
BBAI BigBear.ai | $3.52
+7.5% | 3/7/2025 | Target Lowered by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $7.00 -> $6.00 | High | View details for HC Wainwright rating of BigBear.ai (NYSE:BBAI) on 3/7/2025 |
SRFM Surf Air Mobility | $3.69
+3.9% | 3/7/2025 | Initiated by | HC Wainwright | Analyst Amit Dayal | Buy | $12.00 | High | View details for HC Wainwright rating of Surf Air Mobility (NYSE:SRFM) on 3/7/2025 |
GORO Gold Resource | $0.49
-7.1% | 3/7/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.75 -> $1.25 | High | View details for HC Wainwright rating of Gold Resource (NYSE:GORO) on 3/7/2025 |
XERS Xeris Biopharma | $4.82
+5.7% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $6.60 -> $8.00 | High | View details for HC Wainwright rating of Xeris Biopharma (NASDAQ:XERS) on 3/7/2025 |
PHAT Phathom Pharmaceuticals | $4.41
+4.5% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $28.00 -> $28.00 | High | View details for HC Wainwright rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 3/7/2025 |
SLN Silence Therapeutics | $3.91
-3.7% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $75.00 -> $75.00 | High | View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 3/7/2025 |
MNMD Mind Medicine (MindMed) | $6.35
+0.6% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $55.00 -> $55.00 | Medium | View details for HC Wainwright rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 3/7/2025 |
ALXO ALX Oncology | $0.83
-0.2% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of ALX Oncology (NASDAQ:ALXO) on 3/7/2025 |
DCTH Delcath Systems | $12.58
+4.1% | 3/7/2025 | Target Raised by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $22.00 -> $24.00 | High | View details for HC Wainwright rating of Delcath Systems (NASDAQ:DCTH) on 3/7/2025 |
FHTX Foghorn Therapeutics | $4.43
-1.1% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $13.00 -> $13.00 | Medium | View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 3/7/2025 |
ACET Adicet Bio | $0.78
+0.9% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst E. White | Neutral -> Neutral | | Medium | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 3/7/2025 |
NXTC NextCure | $0.69
-4.3% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $4.00 -> $3.00 | High | View details for HC Wainwright rating of NextCure (NASDAQ:NXTC) on 3/7/2025 |
CTMX CytomX Therapeutics | $0.65
+10.0% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Neutral | | High | View details for HC Wainwright rating of CytomX Therapeutics (NASDAQ:CTMX) on 3/7/2025 |
AVBP ArriVent BioPharma | $21.00
-3.4% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $39.00 -> $39.00 | High | View details for HC Wainwright rating of ArriVent BioPharma (NASDAQ:AVBP) on 3/7/2025 |
RLAY Relay Therapeutics | $3.66
+7.3% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $16.00 -> $16.00 | Low | View details for HC Wainwright rating of Relay Therapeutics (NASDAQ:RLAY) on 3/7/2025 |
RPTX Repare Therapeutics | $1.10
-1.8% | 3/7/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $10.00 -> $5.00 | Low | View details for HC Wainwright rating of Repare Therapeutics (NASDAQ:RPTX) on 3/7/2025 |
VYNE VYNE Therapeutics | $1.85
-2.6% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $5.75 -> $5.75 | Low | View details for HC Wainwright rating of VYNE Therapeutics (NASDAQ:VYNE) on 3/6/2025 |
CLSD Clearside Biomedical | $0.89
+3.3% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $6.00 -> $6.00 | Medium | View details for HC Wainwright rating of Clearside Biomedical (NASDAQ:CLSD) on 3/6/2025 |
BLFS BioLife Solutions | $25.00
-0.2% | 3/6/2025 | Target Raised by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $27.00 -> $30.00 | Low | View details for HC Wainwright rating of BioLife Solutions (NASDAQ:BLFS) on 3/6/2025 |
BWEN Broadwind | $1.48
+1.4% | 3/6/2025 | Target Lowered by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $8.00 -> $6.00 | Medium | View details for HC Wainwright rating of Broadwind (NASDAQ:BWEN) on 3/6/2025 |
ALTO Alto Ingredients | $1.32
| 3/6/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $5.50 -> $5.50 | High | View details for HC Wainwright rating of Alto Ingredients (NASDAQ:ALTO) on 3/6/2025 |
FTEK Fuel Tech | $0.98
| 3/6/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $4.00 -> $4.00 | Low | View details for HC Wainwright rating of Fuel Tech (NASDAQ:FTEK) on 3/6/2025 |
ITOS iTeos Therapeutics | $7.32
+1.8% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $46.00 -> $46.00 | Low | View details for HC Wainwright rating of iTeos Therapeutics (NASDAQ:ITOS) on 3/6/2025 |
OCGN Ocugen | $0.54
-1.0% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $8.00 -> $8.00 | High | View details for HC Wainwright rating of Ocugen (NASDAQ:OCGN) on 3/6/2025 |
EYPT EyePoint Pharmaceuticals | $6.52
-4.5% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 3/6/2025 |
TCRX TScan Therapeutics | $1.74
-2.8% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of TScan Therapeutics (NASDAQ:TCRX) on 3/6/2025 |
KMDA Kamada | $7.18
-0.7% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of Kamada (NASDAQ:KMDA) on 3/6/2025 |
TARA Protara Therapeutics | $4.31
+7.2% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $23.00 -> $23.00 | High | View details for HC Wainwright rating of Protara Therapeutics (NASDAQ:TARA) on 3/6/2025 |
HALO Halozyme Therapeutics | $62.27
+2.0% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | | Low | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 3/6/2025 |
CING Cingulate | $3.59
-1.1% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of Cingulate (NASDAQ:CING) on 3/6/2025 |
AXSM Axsome Therapeutics | $121.91
+0.2% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $200.00 -> $200.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 3/6/2025 |
IBRX ImmunityBio | $2.87
-1.0% | 3/6/2025 | Initiated by | HC Wainwright | Analyst Andrew Fein | Buy | $8.00 | Low | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 3/6/2025 |
OLMA Olema Pharmaceuticals | $4.41
+0.9% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 3/5/2025 |
CMRX Chimerix | $8.46
-0.1% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Neutral | $11.00 -> $8.55 | High | View details for HC Wainwright rating of Chimerix (NASDAQ:CMRX) on 3/5/2025 |
BTCM BIT Mining | $1.95
+7.1% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Neutral -> Neutral | | High | View details for HC Wainwright rating of BIT Mining (NYSE:BTCM) on 3/5/2025 |
PLUG Plug Power | $1.66
+0.6% | 3/5/2025 | Target Lowered by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $5.00 -> $3.00 | High | View details for HC Wainwright rating of Plug Power (NASDAQ:PLUG) on 3/5/2025 |
EOLS Evolus | $13.20
+1.9% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $27.00 -> $27.00 | Medium | View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 3/5/2025 |
RIGL Rigel Pharmaceuticals | $20.13
+1.1% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $57.00 -> $57.00 | High | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 3/5/2025 |
IOBT IO Biotech | $0.88
-1.3% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $12.00 -> $12.00 | Low | View details for HC Wainwright rating of IO Biotech (NASDAQ:IOBT) on 3/5/2025 |
SENS Senseonics | $0.59
+4.7% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $2.00 -> $2.00 | Medium | View details for HC Wainwright rating of Senseonics (NYSE:SENS) on 3/5/2025 |
TIL Instil Bio | $19.88
+4.3% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $110.00 -> $110.00 | N/A | View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 3/5/2025 |
WVE Wave Life Sciences | $10.22
-0.5% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of Wave Life Sciences (NASDAQ:WVE) on 3/5/2025 |
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia…
Listen up, because according to Nvidia's own CEO…
Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th. |
AMLX Amylyx Pharmaceuticals | $3.63
-1.1% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 3/5/2025 |
NTLA Intellia Therapeutics | $9.14
-0.9% | 3/5/2025 | Initiated by | HC Wainwright | Analyst Mitchell Kapoor | Buy | $30.00 | Low | View details for HC Wainwright rating of Intellia Therapeutics (NASDAQ:NTLA) on 3/5/2025 |
CAPR Capricor Therapeutics | $13.23
+3.4% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $77.00 -> $77.00 | High | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 3/4/2025 |
QURE uniQure | $14.20
+3.0% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $70.00 -> $70.00 | High | View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 3/4/2025 |
CMPS COMPASS Pathways | $3.48
-0.3% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $45.00 -> $45.00 | Medium | View details for HC Wainwright rating of COMPASS Pathways (NASDAQ:CMPS) on 3/4/2025 |
SAVA Cassava Sciences | $2.79
+6.9% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst V. Bernardino | Neutral -> Neutral | | High | View details for HC Wainwright rating of Cassava Sciences (NASDAQ:SAVA) on 3/4/2025 |
PLRX Pliant Therapeutics | $1.54
+1.3% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst E. Arce | Neutral -> Neutral | | High | View details for HC Wainwright rating of Pliant Therapeutics (NASDAQ:PLRX) on 3/4/2025 |
ESPR Esperion Therapeutics | $1.50
| 3/4/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | Low | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 3/4/2025 |
BHVN Biohaven | $29.24
+3.6% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $54.00 -> $54.00 | High | View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 3/4/2025 |
CALC CalciMedica | $1.98
+4.2% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of CalciMedica (NASDAQ:CALC) on 3/4/2025 |
CAN Canaan | $1.11
+6.7% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of Canaan (NASDAQ:CAN) on 3/4/2025 |
HUT Hut 8 | $12.62
+7.8% | 3/4/2025 | Target Lowered by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $35.00 -> $30.00 | Medium | View details for HC Wainwright rating of Hut 8 (NASDAQ:HUT) on 3/4/2025 |
SNDX Syndax Pharmaceuticals | $12.95
-1.1% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $51.00 -> $51.00 | High | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 3/4/2025 |
TGTX TG Therapeutics | $40.84
+10.2% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $55.00 -> $55.00 | High | View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 3/4/2025 |
AVDL Avadel Pharmaceuticals | $8.33
-0.7% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $21.00 -> $21.00 | High | View details for HC Wainwright rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 3/4/2025 |
NMRA Neumora Therapeutics | $1.28
-8.6% | 3/4/2025 | Target Lowered by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $30.00 -> $18.00 | Medium | View details for HC Wainwright rating of Neumora Therapeutics (NASDAQ:NMRA) on 3/4/2025 |
OCUL Ocular Therapeutix | $7.72
-2.0% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 3/4/2025 |
ANAB AnaptysBio | $16.73
-0.7% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | $22.00 -> $22.00 | Medium | View details for HC Wainwright rating of AnaptysBio (NASDAQ:ANAB) on 3/4/2025 |
EKSO Ekso Bionics | $0.42
-7.8% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $9.00 -> $9.00 | High | View details for HC Wainwright rating of Ekso Bionics (NASDAQ:EKSO) on 3/4/2025 |
EBS Emergent BioSolutions | $5.74
+4.1% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Emergent BioSolutions (NYSE:EBS) on 3/4/2025 |
ALT Altimmune | $5.92
+13.8% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 3/3/2025 |
LXRX Lexicon Pharmaceuticals | $0.37
+2.7% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for HC Wainwright rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 3/3/2025 |
PTGX Protagonist Therapeutics | $54.78
-0.2% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $54.00 -> $54.00 | High | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 3/3/2025 |
VYGR Voyager Therapeutics | $3.90
-4.2% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 3/3/2025 |
MBRX Moleculin Biotech | $1.13
-2.6% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of Moleculin Biotech (NASDAQ:MBRX) on 3/3/2025 |
PRME Prime Medicine | $1.79
+4.1% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Arthur He | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Prime Medicine (NYSE:PRME) on 3/3/2025 |
INTZ Intrusion | $1.13
-0.9% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Neutral -> Neutral | $1.00 -> $1.00 | High | View details for HC Wainwright rating of Intrusion (NASDAQ:INTZ) on 3/3/2025 |
SOUN SoundHound AI | $10.34
+16.0% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $26.00 -> $26.00 | High | View details for HC Wainwright rating of SoundHound AI (NASDAQ:SOUN) on 3/3/2025 |
CLMT Calumet Specialty Products Partners | $12.06
+7.1% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $33.00 -> $33.00 | High | View details for HC Wainwright rating of Calumet Specialty Products Partners (NASDAQ:CLMT) on 3/3/2025 |
ANIP ANI Pharmaceuticals | $62.49
+1.7% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $94.00 -> $94.00 | High | View details for HC Wainwright rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 3/3/2025 |
NUVL Nuvalent | $77.01
+3.4% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $110.00 -> $110.00 | High | View details for HC Wainwright rating of Nuvalent (NASDAQ:NUVL) on 3/3/2025 |
JANX Janux Therapeutics | $30.68
-2.1% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $70.00 -> $70.00 | High | View details for HC Wainwright rating of Janux Therapeutics (NASDAQ:JANX) on 3/3/2025 |
APLS Apellis Pharmaceuticals | $24.66
+1.2% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $57.00 -> $57.00 | High | View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 3/3/2025 |
PRAX Praxis Precision Medicines | $38.28
+2.7% | 3/3/2025 | Target Lowered by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $120.00 -> $105.00 | High | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 3/3/2025 |
SCPH scPharmaceuticals | $3.03
+1.3% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of scPharmaceuticals (NASDAQ:SCPH) on 3/3/2025 |
SLNO Soleno Therapeutics | $49.34
+0.6% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $70.00 -> $70.00 | High | View details for HC Wainwright rating of Soleno Therapeutics (NASDAQ:SLNO) on 3/3/2025 |
LGVN Longeveron | $1.69
+3.0% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Longeveron (NASDAQ:LGVN) on 3/3/2025 |
RYTM Rhythm Pharmaceuticals | $50.97
+1.5% | 3/3/2025 | Target Raised by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $69.00 -> $70.00 | Medium | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 3/3/2025 |
ALMS Alumis | $4.57
-0.4% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $19.00 -> $19.00 | Medium | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 3/3/2025 |
AKRO Akero Therapeutics | $44.15
-1.6% | 3/3/2025 | Target Raised by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $72.00 -> $75.00 | High | View details for HC Wainwright rating of Akero Therapeutics (NASDAQ:AKRO) on 3/3/2025 |
CDNA CareDx | $18.90
+7.1% | 3/3/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Neutral -> Neutral | $26.00 -> $25.00 | High | View details for HC Wainwright rating of CareDx (NASDAQ:CDNA) on 3/3/2025 |
OPK OPKO Health | $1.74
+1.2% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $3.00 -> $3.00 | Low | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 3/3/2025 |
MRUS Merus | $47.10
-1.1% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $85.00 -> $85.00 | Medium | View details for HC Wainwright rating of Merus (NASDAQ:MRUS) on 3/3/2025 |
FDMT 4D Molecular Therapeutics | $4.11
-4.0% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $36.00 -> $36.00 | High | View details for HC Wainwright rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 3/3/2025 |
ALDX Aldeyra Therapeutics | $6.91
+1.5% | 3/3/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 3/3/2025 |
RVMD Revolution Medicines | $39.12
+0.2% | 3/3/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $72.00 -> $73.00 | High | View details for HC Wainwright rating of Revolution Medicines (NASDAQ:RVMD) on 3/3/2025 |
HURA TuHURA Biosciences | $2.28
+15.2% | 3/3/2025 | Initiated by | HC Wainwright | Analyst Robert Burns | Buy | $13.00 | High | View details for HC Wainwright rating of TuHURA Biosciences (NASDAQ:HURA) on 3/3/2025 |
VALN Valneva | $6.80
+0.1% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 2/28/2025 |
ETNB 89bio | $8.47
+3.5% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $29.00 -> $21.00 | High | View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 2/28/2025 |
IMCR Immunocore | $28.80
+1.9% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $100.00 -> $100.00 | Low | View details for HC Wainwright rating of Immunocore (NASDAQ:IMCR) on 2/28/2025 |
A brutally honest economic warning for 2025 (see proof) (Ad) New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says.... Full details here. |
VIR Vir Biotechnology | $7.15
+2.1% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $110.00 -> $110.00 | High | View details for HC Wainwright rating of Vir Biotechnology (NASDAQ:VIR) on 2/28/2025 |
CPRX Catalyst Pharmaceuticals | $21.02
+0.7% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $35.00 -> $35.00 | High | View details for HC Wainwright rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 2/28/2025 |
KRYS Krystal Biotech | $179.38
+1.1% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $221.00 -> $221.00 | Medium | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 2/28/2025 |
MIST Milestone Pharmaceuticals | $2.17
+6.9% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 2/28/2025 |
BEAM Beam Therapeutics | $24.23
-3.3% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $80.00 -> $80.00 | Low | View details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 2/28/2025 |
NPKI NPK International | $6.15
+3.4% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $12.00 -> $12.00 | Low | View details for HC Wainwright rating of NPK International (NYSE:NPKI) on 2/28/2025 |
ACHR Archer Aviation | $7.88
+8.6% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $12.50 -> $12.50 | High | View details for HC Wainwright rating of Archer Aviation (NYSE:ACHR) on 2/28/2025 |
GLDG GoldMining | $0.86
| 2/28/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $5.50 -> $3.25 | N/A | View details for HC Wainwright rating of GoldMining (NYSEAMERICAN:GLDG) on 2/28/2025 |
UUUU Energy Fuels | $4.13
-1.2% | 2/28/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $11.00 -> $10.75 | N/A | View details for HC Wainwright rating of Energy Fuels (NYSEAMERICAN:UUUU) on 2/28/2025 |
CGEM Cullinan Therapeutics | $8.79
-1.5% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $33.00 -> $33.00 | High | View details for HC Wainwright rating of Cullinan Therapeutics (NASDAQ:CGEM) on 2/28/2025 |
PBYI Puma Biotechnology | $3.32
-0.6% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Puma Biotechnology (NASDAQ:PBYI) on 2/28/2025 |
CYTK Cytokinetics | $44.36
-0.1% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $120.00 -> $120.00 | Low | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 2/28/2025 |
CLDX Celldex Therapeutics | $20.42
+1.4% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 2/28/2025 |
IOVA Iovance Biotherapeutics | $3.59
+2.0% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $32.00 -> $32.00 | High | View details for HC Wainwright rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 2/28/2025 |
VCEL Vericel | $45.38
0.0% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $60.00 -> $60.00 | High | View details for HC Wainwright rating of Vericel (NASDAQ:VCEL) on 2/28/2025 |
PSNL Personalis | $3.63
+1.7% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of Personalis (NASDAQ:PSNL) on 2/28/2025 |
ARGX argenx | $604.96
+4.1% | 2/28/2025 | Target Raised by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $717.00 -> $720.00 | Medium | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 2/28/2025 |
PCRX Pacira BioSciences | $22.87
+0.8% | 2/28/2025 | Target Raised by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $57.00 -> $70.00 | High | View details for HC Wainwright rating of Pacira BioSciences (NASDAQ:PCRX) on 2/28/2025 |
OPT Opthea | $3.18
+3.6% | 2/28/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Opthea (NASDAQ:OPT) on 2/28/2025 |
VRNA Verona Pharma | $61.39
-6.1% | 2/28/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $60.00 -> $75.00 | Medium | View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 2/28/2025 |
CRDF Cardiff Oncology | $4.00
+1.3% | 2/28/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $13.00 -> $17.00 | High | View details for HC Wainwright rating of Cardiff Oncology (NASDAQ:CRDF) on 2/28/2025 |
VERV Verve Therapeutics | $5.97
-2.9% | 2/28/2025 | Target Raised by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $14.00 -> $15.00 | Medium | View details for HC Wainwright rating of Verve Therapeutics (NASDAQ:VERV) on 2/28/2025 |
DNLI Denali Therapeutics | $15.15
+1.7% | 2/28/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $80.00 -> $87.00 | High | View details for HC Wainwright rating of Denali Therapeutics (NASDAQ:DNLI) on 2/28/2025 |
KYMR Kymera Therapeutics | $34.37
+2.8% | 2/28/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $54.00 -> $60.00 | High | View details for HC Wainwright rating of Kymera Therapeutics (NASDAQ:KYMR) on 2/28/2025 |
DYN Dyne Therapeutics | $12.05
+1.4% | 2/28/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $55.00 -> $46.00 | Medium | View details for HC Wainwright rating of Dyne Therapeutics (NASDAQ:DYN) on 2/28/2025 |
MIRM Mirum Pharmaceuticals | $44.28
-0.6% | 2/28/2025 | Target Raised by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $66.00 -> $72.00 | Low | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 2/28/2025 |
ATXS Astria Therapeutics | $6.45
-2.9% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | Medium | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 2/27/2025 |
UTHR United Therapeutics | $307.24
+0.6% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $425.00 -> $425.00 | High | View details for HC Wainwright rating of United Therapeutics (NASDAQ:UTHR) on 2/27/2025 |
ACAD ACADIA Pharmaceuticals | $17.50
+4.3% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $27.00 -> $27.00 | High | View details for HC Wainwright rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 2/27/2025 |
ACET Adicet Bio | $0.78
+0.9% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst E. White | Neutral -> Neutral | | High | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 2/27/2025 |
LVTX LAVA Therapeutics | $1.30
-2.3% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst Arthur He | Buy -> Neutral | $2.00 -> $1.50 | Low | View details for HC Wainwright rating of LAVA Therapeutics (NASDAQ:LVTX) on 2/27/2025 |
ALEC Alector | $1.45
+1.4% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Alector (NASDAQ:ALEC) on 2/27/2025 |
MARA MARA | $13.18
+8.4% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $28.00 -> $28.00 | High | View details for HC Wainwright rating of MARA (NASDAQ:MARA) on 2/27/2025 |
LPTH LightPath Technologies | $2.08
+7.8% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for HC Wainwright rating of LightPath Technologies (NASDAQ:LPTH) on 2/27/2025 |
CORZ Core Scientific | $8.81
+1.7% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $17.00 -> $17.00 | High | View details for HC Wainwright rating of Core Scientific (NASDAQ:CORZ) on 2/27/2025 |
JOBY Joby Aviation | $6.25
+4.3% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $9.00 -> $9.00 | High | View details for HC Wainwright rating of Joby Aviation (NYSE:JOBY) on 2/27/2025 |
HRMY Harmony Biosciences | $32.72
| 2/27/2025 | Target Lowered by | HC Wainwright | Analyst P. Trucchio | Buy -> Buy | $75.00 -> $70.00 | Medium | View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 2/27/2025 |
CORT Corcept Therapeutics | $56.01
+2.1% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $115.00 -> $115.00 | High | View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 2/27/2025 |
KROS Keros Therapeutics | $11.58
+1.0% | 2/27/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $47.00 -> $40.00 | Low | View details for HC Wainwright rating of Keros Therapeutics (NASDAQ:KROS) on 2/27/2025 |
KURA Kura Oncology | $7.14
-1.9% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 2/27/2025 |
SRPT Sarepta Therapeutics | $97.19
-1.2% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Sell -> Sell | $75.00 -> $75.00 | Medium | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 2/27/2025 |
MLTX MoonLake Immunotherapeutics | $38.55
+1.9% | 2/27/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $100.00 -> $100.00 | High | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 2/27/2025 |
MDGL Madrigal Pharmaceuticals | $348.35
+7.8% | 2/27/2025 | Target Raised by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $400.00 -> $405.00 | High | View details for HC Wainwright rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 2/27/2025 |
ARQT Arcutis Biotherapeutics | $14.62
-1.3% | 2/26/2025 | Reiterated by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $19.00 -> $19.00 | High | View details for HC Wainwright rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 2/26/2025 |
GERN Geron | $1.64
-1.8% | 2/26/2025 | Downgraded by | HC Wainwright | Analyst E. Bodnar | Buy -> Neutral | | High | View details for HC Wainwright rating of Geron (NASDAQ:GERN) on 2/26/2025 |
FEMY Femasys | $1.57
+12.1% | 2/26/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $12.00 -> $12.00 | Low | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 2/26/2025 |
BTDR Bitdeer Technologies Group | $10.35
+5.8% | 2/26/2025 | Reiterated by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $22.00 -> $21.00 | Medium | View details for HC Wainwright rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 2/26/2025 |
CIFR Cipher Mining | $3.04
+0.3% | 2/26/2025 | Reiterated by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of Cipher Mining (NASDAQ:CIFR) on 2/26/2025 |
CECO CECO Environmental | $23.25
+1.6% | 2/26/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Neutral -> Neutral | | Medium | View details for HC Wainwright rating of CECO Environmental (NASDAQ:CECO) on 2/26/2025 |
BCYC Bicycle Therapeutics | $9.69
+0.6% | 2/26/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $33.00 -> $33.00 | High | View details for HC Wainwright rating of Bicycle Therapeutics (NASDAQ:BCYC) on 2/26/2025 |
DAWN Day One Biopharmaceuticals | $8.12
-6.7% | 2/26/2025 | Target Lowered by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $40.00 -> $36.00 | High | View details for HC Wainwright rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 2/26/2025 |
TARS Tarsus Pharmaceuticals | $48.09
+3.5% | 2/26/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $73.00 -> $73.00 | High | View details for HC Wainwright rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 2/26/2025 |
NERV Minerva Neurosciences | $1.54
-4.9% | 2/26/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Neutral -> Neutral | $5.00 -> $5.00 | Low | View details for HC Wainwright rating of Minerva Neurosciences (NASDAQ:NERV) on 2/26/2025 |
KPTI Karyopharm Therapeutics | $6.75
-2.7% | 2/26/2025 | Target Raised by | HC Wainwright | Analyst Edward White | Buy -> Buy | $7.00 -> $56.00 | Low | View details for HC Wainwright rating of Karyopharm Therapeutics (NASDAQ:KPTI) on 2/26/2025 |
RGLS Regulus Therapeutics | $1.48
+7.2% | 2/26/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Regulus Therapeutics (NASDAQ:RGLS) on 2/26/2025 |
FULC Fulcrum Therapeutics | $3.12
+7.6% | 2/26/2025 | Reiterated by | HC Wainwright | Analyst A. Fein | Neutral -> Neutral | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Fulcrum Therapeutics (NASDAQ:FULC) on 2/26/2025 |
CADL Candel Therapeutics | $8.75
+10.2% | 2/26/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $19.00 -> $19.00 | Medium | View details for HC Wainwright rating of Candel Therapeutics (NASDAQ:CADL) on 2/26/2025 |
RCUS Arcus Biosciences | $9.35
-2.0% | 2/26/2025 | Upgraded by | HC Wainwright | Analyst E. Bodnar | Neutral -> Buy | $18.00 -> $24.00 | Low | View details for HC Wainwright rating of Arcus Biosciences (NYSE:RCUS) on 2/26/2025 |
NVCT Nuvectis Pharma | $8.85
+6.0% | 2/25/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $21.00 -> $11.00 | Medium | View details for HC Wainwright rating of Nuvectis Pharma (NASDAQ:NVCT) on 2/25/2025 |
CLNN Clene | $4.43
+1.4% | 2/25/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $31.00 -> $31.00 | Low | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 2/25/2025 |
